Is China SXT Pharmaceuticals, Inc. (SXTC) a Buy, Sell, or Hold?
China SXT Pharmaceuticals, Inc.
NASDAQ:SXTC
$2.41 USD
-$0.16 (-6.23%)
- Volume
- 33.8K
- Average Volume
- 66.83K
- Market Capitalization
- $1.64M
- P/E Ratio
- -0.29
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $1047.00
- Year Low
- $1.25
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.93
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Feng Zhou |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Current Symbol | SXTC |
| CUSIP | G2161P165 |
| CIK | 0001723980 |
| Web | http://www.sxtchina.com |
| Phone | 86 523 8629 8290 |
| Currency | USD |
| Employees | 56 |
| Country | CN |
Liquidity
| Debt-to-Equity Ratio | 0.04 |
| Payout Ratio | 0.00 |
| Current Ratio | 7.93 |
| Quick Ratio | 7.25 |
| Cash Ratio | 6.48 |
Sales & Book Value
| Annual Sales | $1.07M |
| Price / Sales | 0.65 |
| Cash Flow | -5.38 |
| Price / Cash Flow | -0.32 |
| Price / Book | 0.08 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Neutral |
| Rating Score(0-5) | 3 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-9.13 |
| Trailing P/E Ratio | -0.29 |
| PEG Ratio | 0.00 |
| P/E Growth | 0.00 |
| Net Income | $-6.21M |
| Net Margin | -290.71% |
| Pretax Margin | -344.88% |
| Return on Equity | -31.02% |
| Return on Assets | -21.22% |
Financials Score
| AltmanZ Score | -0.87 |
| Piotroski Score | 4.00 |
| Working Capital | 30.16M |
| Total Assets | 34.75M |
| Ebit | -8.54M |
| Market Cap | 1.74M |
| Total Liabilities | 5.05M |
Poll Results
About China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Stock
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China. ...
Frequently Asked Questions
-
What is the current China SXT Pharmaceuticals, Inc. (SXTC) stock price?
-
China SXT Pharmaceuticals, Inc.(NASDAQ:SXTC) stock price is $2.41 in the last trading session. During the trading session, SXTC stock reached the peak price of $1047 while $1.25 was the lowest point it dropped to. The percentage change in SXTC stock occurred in the recent session was --6.23% while the dollar amount for the price change in SXTC stock was -$-0.16.
-
SXTC's industry and sector of operation?
-
The NASDAQ listed SXTC is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of SXTC?
-
Feng Zhou | Chairman of the Board & Co-CEO
Jun Zheng | Executive Director
Sze Beng Lim | Co-Chief Executive Officer
Xiaodong Pan | Chief Financial Officer
| -
How many employees does SXTC have?
-
Number of SXTC employees currently stands at 56. SXTC operates from 178 Taidong Road North, Taizhou, JS 225300, CN.
-
Link for SXTC official website?
-
Official Website of SXTC is: http://www.sxtchina.com
-
How do I contact SXTC?
-
SXTC could be contacted at phone #86 523 8629 8290 and can also be accessed through its website. SXTC operates from 178 Taidong Road North, Taizhou, JS 225300, CN.
-
How many shares of SXTC are traded daily?
-
The average number of SXTC shares traded daily for last 3 months was 66.83K.
-
What is the market cap of SXTC currently?
-
The market value of SXTC currently stands at $1.64M with its latest stock price at $2.41